CRTH2 antagonists in asthma: current perspectives
Dave Singh, Arjun Ravi, Thomas Southworth Division of Infection, Immunity and Respiratory Medicine, The Medicines Evaluation Unit, Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, The University of Manchester, Manchester, UK Abstract: Chemoattr...
Guardado en:
Autores principales: | Singh D, Ravi A, Southworth T |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/af653f6e2cb94424bf414501e6e6785e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Updated Evaluation of Dupilumab in the Treatment of Asthma: Patient Selection and Reported Outcomes
por: Brooks GD
Publicado: (2020) -
Insights into the Implications of Coexisting Type 2 Inflammatory Diseases
por: McCormick JP, et al.
Publicado: (2021) -
Managing Exacerbations in Thunderstorm Asthma: Current Insights
por: Chatelier J, et al.
Publicado: (2021) -
Altered Pattern of Macrophage Polarization as a Biomarker for Severity of Childhood Asthma
por: Kuo CH, et al.
Publicado: (2021) -
Recent Insights into the Management of Inflammation in Asthma
por: Rupani H, et al.
Publicado: (2021)